SCHEMBL8425367

SCHEMBL8425367

CCCN(C(C)=O)c1ccc(C(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.43
MLYCD O95822 2/20 0.42
NOS1 P29475 1/20 0.41
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
PARP4 Q9UKK3 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
PARP1 P09874 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
CYP2C9 P11712 2/20 0.39
HSD17B10 Q99714 2/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
APAF1 O14727 1/20 0.38
RGS12 O14924 1/20 0.38
HSP90AA1 P07900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048720 0.90 MAPK1 (0.43) PARP10MLYCDNOS1MAPK1SMN1; SMN2
SCHEMBL17670515 0.82 NPC1 (0.38) PARP10NOS1SMN1; SMN2ALDH1A1PARP4
SCHEMBL22241398 0.81 MLYCD (0.41) MLYCDSMN1; SMN2ALDH1A1EGFRERBB2
SCHEMBL6698097 0.80 TP53 (0.44) MLYCDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL15215895 0.79 POLB (0.49) MLYCDALDH1A1KMT2AMEN1TP53
SCHEMBL8016233 0.79 MLYCD (0.40) MLYCDSMN1; SMN2ALDH1A1EGFRERBB2
SCHEMBL2069635 0.78 TP53 (0.59) SMN1; SMN2ALDH1A1CYP2C9KMT2AMEN1
SCHEMBL22241317 0.76 MLYCD (0.38) MLYCDSMN1; SMN2ALDH1A1EGFRERBB2
SCHEMBL22241327 0.76 MLYCD (0.38) MLYCDSMN1; SMN2ALDH1A1EGFRERBB2
SCHEMBL5510305 0.75 TP53 (0.40) MLYCDSMN1; SMN2ALDH1A1CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5955506-A ACETAMIDOBENZAMIDE COMPOUNDS FOR TREATMENT OF PARKINSON'S DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-09-21 US disclosed